Main Menu
Print PDF

Life Sciences

The Life Sciences Group has extensive experience representing clients in biotech, pharmaceuticals, medical devices and diagnostics, and healthcare IT. Our multidisciplinary team of lawyers handles a broad range of transactions, including the acquisition, sales, development, commercialization, licensing, manufacturing and supply of products, as well as litigation. We also provide assistance with private equity and institutional debt and equity financing. We collaborate with our intellectual property, product liability, tax and employment practices to provide clients with the business and legal experience needed to be successful in a competitive, innovative and highly regulated market.

Life sciences may be one of the fastest growing and most closely watched industries. For that reason it’s important that we monitor changes in the business, legal and regulatory landscape so we can effectively counsel clients through the life cycle of their business. Our lawyers are involved in various industry groups, including Life Sciences PA and ELabNYC, which provide opportunities for education, engagement and advocacy. We are founding members of the Life Sciences Collaborative, a group of industry professionals who share a common vision of increasing the success of emerging life sciences businesses in the Mid-Atlantic Region, and a sponsor of MentorConnect, a collaboration of the Philadelphia Alliance for Capital and Technologies (PACT) and Ben Franklin Technology Partners, which helps high-potential entrepreneurs with development of the business skills they need to bring ideas and inventions to market.

Representative Matters

  • Represented a foreign manufacturer of pharmaceutical products and medical devices in the acquisition of world wide marketing and distribution rights to a line of products
  • Represented the strategic investment arm of a life and disability insurer in connection with its investment in a healthcare IT company that leverages clinical diagnostic data and AI to develop advanced analytics solutions for the healthcare, pharmaceutical and life science markets
  • Represented a European-based pharmaceutical manufacturing, development and distribution company in the sale of worldwide distribution rights to a line of products, including the drafting and negotiation of an asset purchase agreement, a commercialization, development and license agreement and related manufacturing and supply agreement
  • Represented a privately held U.S.-based pharmaceutical manufacturer and development company in obtaining private equity financing from U.S. and European-based private equity funds. This representation included the negotiation and drafting of a stock purchase agreement and related investor rights agreement necessary to balance the interests of existing ownership and the new private equity investors.
  • Represented a privately held medical device development firm in the license of a patent-pending drug delivery instrument from a publicly traded pharmaceutical company
  • Negotiated and drafted strategic alliance, clinical trial and product development related agreements for small and mid-sized life science companies, including CRO, CMO and site agreements
  • Lead regional counsel to national medical publisher and database distributor in tort litigation alleging inadequate technical specifications, failure to warn of pharmaceutical product hazards
  • National litigation counsel for medical device manufacturer in federal MDL and related state tort proceedings involving product allergy and related injuries
  • Represented the shareholders of a privately held specialty engineering firm catering to the pharmaceutical industry in connection with the sale of the firm to a publicly traded international engineering firm
  • Counseling and IP portfolio development for gene-therapy based CNS therapeutic company
  • Provided startup, venture capital and intellectual property advice to life science company with research centers in the U.S. and Germany providing technology and scientific expertise for biotechnological and pharmaceutical companies.
  • Represented healthcare IT company in a strategic alliance with a Fortune 50 healthcare company to co-develop and co-market software to minimize adverse drug interactions

Events

Back to Page